Skip to main content

Find Clinical Trials

Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Pharmacokinetics, Tolerability and Safety of NEX-18a

NCT05048498

Conditions: Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +15 more
Locations: Karolinska University Hospital Huddinge Huddinge, Sweden

Kliniska Forsknings och Utvecklings Enheten KFUE Uppsala, Sweden

View Trial Details

Completed

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

NCT03096782

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, +59 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

NCT02767388

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +42 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

NCT00003838

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +23 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Allo HSCT Using RIC for Hematological Diseases

NCT02661035

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, B-cell Lymphoma, +59 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

NCT01696461

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +31 more
Locations: H. Lee Moffitt Cancer Center Tampa, Florida, United States

Emory University Atlanta, Georgia, United States

University of Chicago Chicago, Illinois, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention

NCT01951885

Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +41 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT04402541

Conditions: Acute Myeloid Leukemia, in Relapse, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

KU Clinical Research Center Fairway, Kansas, United States

Memorial Sloan Kettering Cancer Center New York, United States

Weill Cornel Medical Center New York, United States

View Trial Details

Completed

Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat

NCT04712942

Conditions: Acute Myeloid Leukemia in Remission, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Medizinische Klinik IV - Hämatologie und Onkologie, Universitätsklinikum Aachen Aachen, Germany

Zentrum Hämatologie, Onkologie, Palliativmedizin, Helios Klinikum Berlin-Buch GmbH Berlin, Germany

Klinik für Innere Medizin III, Hämatologie, Onkologie, Stammzelltransplantation, Klinikum Chemnitz gGmbH Chemnitz, Germany

Hämatologie/Internistische Onkologie, Onkologische Tagesklinik Cottbus, Germany

View all 14 locations

View Trial Details

Completed

Validation of a Predictive Model of Response to Romiplostim in Patients With IPSS Low or Intermediate-1 Risk MDS and Thrombocytopenia

NCT02335268

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: CH Annecy, France

CH Victor Dupouy Argenteuil, France

CH Henri Duffaut Avignon, France

CHU de Haut Lévèque Bordeaux, France

View all 36 locations

View Trial Details